VEGFR endocytosis: Implications for angiogenesis

• DOI: 10.1016/bs.pmbts.2022.06.021
• Publication Date: 2022-07-15T01:21:30Z
• Authors: Queen Saikia; Hannah Reeve; Areej Alzahrani; William R. Critchley; Elton Zeqiraj; Aysha Divan; Michael A. Harrison; Sreenivasan Ponna...
• Keywords: Lymphangiogenesis; Vasculogenesis

The binding of vascular endothelial growth factor (VEGF) superfamily to VEGF receptor tyrosine kinases (VEGFRs) and co-receptors regulates vasculogenesis, angiogenesis and lymphangiogenesis. A recurring theme is that dysfunction in VEGF signaling promotes pathological angiogenesis, an important feature of cancer and pro-inflammatory disease states. Endocytosis of basal (resting) or activated VEGFRs facilitates signal attenuation and endothelial quiescence. However, increasing evidence suggest that activated VEGFRs can continue to signal from intracellular compartments such as endosomes. In this chapter, we focus on the evolving link between VEGFR endocytosis, signaling and turnover and the implications for angiogenesis. There is much interest in how such understanding of VEGFR dynamics can be harnessed therapeutically for a wide range of human disease states.